Jeffrey Trigilio
2023
In 2023, Jeffrey Trigilio earned a total compensation of $2.2M as Former Chief Financial Officer at Cullinan Therapeutics, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $404,811 |
|---|---|
| Option Awards | $748,739 |
| Salary | $474,600 |
| Stock Awards | $532,980 |
| Other | $43,203 |
| Total | $2,204,333 |
Trigilio received $748.7K in option awards, accounting for 34% of the total pay in 2023.
Trigilio also received $404.8K in bonus, $474.6K in salary, $533K in stock awards and $43.2K in other compensation.
Rankings
In 2023, Jeffrey Trigilio's compensation ranked 469th out of 3,006 executives tracked by ExecPay. In other words, Trigilio earned more than 84.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 469 out of 3,006 | 84th |
Division Manufacturing | 269 out of 1,650 | 84th |
Major group Chemicals And Allied Products | 184 out of 918 | 80th |
Industry group Drugs | 181 out of 881 | 80th |
Industry Biological Products, Except Diagnostic Substances | 64 out of 213 | 70th |
Source: SEC filing on May 16, 2024.
Trigilio's colleagues
We found two more compensation records of executives who worked with Jeffrey Trigilio at Cullinan Therapeutics in 2023.